[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[S:9][C:10]([C:14]([NH:16][CH2:17][CH:18]3[CH2:23][CH2:22][CH2:21][N:20]([C:24]4[CH:33]=[CH:32][CH:31]=[CH:30][C:25]=4[C:26]([O:28]C)=[O:27])[CH2:19]3)=[O:15])=[C:11]([CH3:13])[N:12]=2)=[CH:4][CH:3]=1.[OH-].[K+]>CO>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[S:9][C:10]([C:14]([NH:16][CH2:17][CH:18]3[CH2:23][CH2:22][CH2:21][N:20]([C:24]4[CH:33]=[CH:32][CH:31]=[CH:30][C:25]=4[C:26]([OH:28])=[O:27])[CH2:19]3)=[O:15])=[C:11]([CH3:13])[N:12]=2)=[CH:4][CH:3]=1Methyl 2-[3-[[2-(4-chlorophenyl)-4-methylthiazol-5-yl]carbonylaminomethyl]piperidin-1-yl]benzoate (29.5 mg, 0.0609 mmol) was dissolved in methanol (3 mL). To this solution, a 1 mol/L aqueous potassium hydroxide solution (0.183 mL, 0.183 mmol) was added and the mixture was stirred for 2 hours while being refluxed. Subsequently, the reaction mixture was concentrated and water was added to the residue, followed by 2 mol/L hydrochloric acid to make the mixture acidic. The crystallized powdery product was collected by filtration and washed with water to give 23.2 mg (81%) of the desired product as a colorless powder.